NciaNet: A Non-Covalent Interaction-Aware Graph Neural Network for the Prediction of Protein-Ligand Interaction in Drug Discovery
View abstract on PubMed
Summary
This summary is machine-generated.We developed a new AI model, NciaNet, to accurately predict protein-ligand binding affinity by considering non-covalent interactions and 3D structures. This method improves drug discovery accuracy and provides biochemical insights.
Area Of Science
- Computational chemistry
- Artificial intelligence in drug discovery
- Molecular modeling
Background
- Accurate quantification of protein-ligand interactions is crucial for early-stage drug discovery.
- Current AI models often neglect intermolecular non-covalent interactions and 3D spatial structures, limiting accuracy and generalizability.
- Existing deep-learning approaches struggle to capture the nuances of binding affinity prediction.
Purpose Of The Study
- To propose a novel method, Non-covalent Interaction-aware Graph Neural Network (NciaNet), for precise protein-ligand interaction quantification.
- To enhance the accuracy and interpretability of AI models in predicting binding affinity.
- To incorporate intermolecular non-covalent interactions and 3D structural information into AI models.
Main Methods
- Developed NciaNet, a graph neural network model that integrates intermolecular non-covalent interactions and 3D protein-ligand complex structures.
- Utilized benchmark datasets (core set v.2016 and v.2013) for training and validation.
- Compared NciaNet's performance against competitive baseline models.
Main Results
- NciaNet achieved excellent predictive performance on benchmark datasets.
- Achieved an RMSE of 1.208 and R of 0.833 on the core set v.2016.
- Achieved an RMSE of 1.409 and R of 0.805 on the core set v.2013.
- Demonstrated superior performance compared to baseline models in binding affinity prediction.
Conclusions
- NciaNet effectively utilizes non-covalent interactions and 3D structure for accurate binding affinity prediction.
- The model provides valuable biochemical insights into protein-ligand interactions.
- NciaNet shows practical utility and reliability, though generalizability to unseen complexes may require further investigation.
Related Concept Videos
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...